Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide in Children With Autism Spectrum Disorder
NCT04766177Phase 3Recruiting
- Start
- Jan 2021
- Primary completion
- Dec 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bumetanide in Autism Spectrum Disorder (ASD). Started Jan 2021; status: recruiting.
02
Drugs
bumetanide
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04766177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766177.